Literature DB >> 33457693

Bioregenerative Umbilical Cord Amniotic Membrane Allograft Ureteral Wrap During Robot-Assisted Ureterolysis.

Nathan Cheng1, Nermarie Velazquez1, Bethany R Desroches2, Ravi Munver1,3,4.   

Abstract

Omental wrap is commonly performed after ureterolysis to prevent ureteral obstruction from recurrence of periureteral adhesions and fibrosis. We present the case of a 37-year-old Caucasian woman with a history of two cesarean sections and laparotomy for the treatment of endometriosis. She subsequently developed right flank pain caused by a right distal ureteral stricture requiring a chronic indwelling ureteral stent. Diagnostic laparoscopy revealed extrinsic compression of the ureter for which robot-assisted ureterolysis was performed. Because of inadequate omentum, we report the initial use of a cryopreserved bioregenerative umbilical cord amniotic membrane allograft to perform a ureteral wrap to promote ureteral tissue healing and serve as an adhesion barrier to prevent recurrence of the fibrosis. Copyright 2020, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  amniotic membrane allograft; omental wrap; retroperitoneal fibrosis; ureterolysis

Year:  2020        PMID: 33457693      PMCID: PMC7803250          DOI: 10.1089/cren.2020.0185

Source DB:  PubMed          Journal:  J Endourol Case Rep        ISSN: 2379-9889


  3 in total

1.  Novel Role of Dehydrated Human Amnion/Chorion Membrane in Healing of Denuded Ureter in Robot-Assisted Excision of Endometriosis.

Authors:  Osamah Hasan; Grant S Johnson; James J Siegert; Francisco Garcini; Thai T Nguyen
Journal:  Case Rep Obstet Gynecol       Date:  2019-01-15

2.  Robotic ureterolysis for relief of ureteral obstruction from retroperitoneal fibrosis.

Authors:  Aryeh Y Keehn; Patrick W Mufarrij; Michael D Stifelman
Journal:  Urology       Date:  2011-02-05       Impact factor: 2.649

3.  Human Amniotic Membrane and Amniotic Membrane-Derived Cells: How Far Are We from Their Use in Regenerative and Reconstructive Urology?

Authors:  Taja Železnik Ramuta; Mateja Erdani Kreft
Journal:  Cell Transplant       Date:  2018-01       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.